| Literature DB >> 17261191 |
Pie Müller1, Martin J Donnelly, Hilary Ranson.
Abstract
BACKGROUND: Mosquito resistance to the pyrethroid insecticides used to treat bednets threatens the sustainability of malaria control in sub-Saharan Africa. While the impact of target site insensitivity alleles is being widely discussed the implications of insecticide detoxification--though equally important--remains elusive. The successful development of new tools for malaria intervention and management requires a comprehensive understanding of insecticide resistance, including metabolic resistance mechanisms. Although three enzyme families (cytochrome P450s, glutathione S-transferases and carboxylesterases) have been widely associated with insecticide detoxification the role of individual enzymes is largely unknown.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17261191 PMCID: PMC1797171 DOI: 10.1186/1471-2164-8-36
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Microarray analysis comparing the permethrin resistant Odumasy strain with the standard susceptible Kisumu strain. Data are shown for the differences in expression levels between the permethrin resistant Odumasy strain and the standard susceptible Kisumu strain for both females (A) and males (B). Each dot represents the mean estimates, fold (M) and p-value (adjusted for multiple testing), for one gene from the complete microarray experiment. Names are shown for genes that are at least two-fold differentially expressed. Underlined names show genes that are common to both the female-female and male-male comparison. Horizontal line represents the level of significance α = 0.001, and vertical lines indicate two-fold change threshold.
Differential gene expression between the permethrin resistant Odumasy and the susceptible Kisumu strain
| Gene | Function | Cytological position | Accession number | Females | Males | ||
| Fold | Fold | ||||||
| Genes over-expressed in resistant Odumasy strain | |||||||
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 5.2 | 7.94 × 10-05 | 3.2 | 1.29 × 10-11 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 4.2 | 8.62 × 10-07 | 8.0 | 2.27 × 10-11 | |
| Cu-Zn superoxide dismutase | 3L | [GenBank: | 3.5 | 8.11 × 10-04 | 2.0 | 1.00 × 10-04 | |
| Glutathione S-transferase | 3L | GenBank: | 2.5 | 2.91 × 10-04 | - | n.s. | |
| Esterase | 2L | [TIGR: TC77639] | 2.0 | 3.86 × 10-09 | 1.8 | 1.67 × 10-08 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | - | n.s. | 3.0 | 1.54 × 10-07 | |
| Genes over-expressed in the susceptible Kisumu strain | |||||||
| Glutathione S-transferase | 3R | [GenBank: | - | n.s. | 2.7 | 4.61 × 10-04 | |
| Cytochrome P450 monooxygenase | 2R | [GenBank: | 2.3 | 1.06 × 10-06 | 1.6 | 7.32 × 10-11 | |
| Cytochrome P450 monooxygenase | 3L | [GenBank: | 2.0 | 8.76 × 10-06 | - | n.s. | |
| Peroxidase | 3L | [GenBank: | - | n.s. | 7.5 | 6.45 × 10-06 | |
Only genes are listed which showed at least a two-fold difference in one or both sexes. p-values were corrected for multiple testing as described in the materials and methods section. n.s., p ≥ 0.001.
Figure 2Microarray analysis comparing females with males within each strain. Data are shown for the gene expression levels of susceptible Kisumu females vs. males (A) and the permethrin resistant Odumasy females vs. males (B). Each dot represents the mean estimates, fold (M) and p-value (adjusted for multiple testing), for one gene from the complete microarray experiment. Names are shown for genes that are at least two-fold differentially expressed. Underlined names show genes that are common to both the Kisumu female-male and the Odumasy female-male comparison. Horizontal line represents the level of significance α = 0.001, and vertical lines indicate two-fold change threshold. *CYP6Z1 was spotted on the detox chip as both cDNA and 70-mer oligonucleotide probe [16].
Differential gene expression between females and males within each strain
| Gene | Function | Cytological position | Accession number | Kisumu strain | Odumasy strain | ||
| Fold | Fold | ||||||
| Genes over-expressed in males | |||||||
| Cytochrome P450 monooxygenase | X | [GenBank: | 9.6 | 2.31 × 10-08 | 11.7 | 1.20 × 10-17 | |
| Cytochrome P450 monooxygenase | 2R | [GenBank: | 4.4 | 3.67 × 10-07 | 5.7 | 9.29 × 10-16 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 3.9 | 4.88 × 10-04 | 4.0 | 9.04 × 10-06 | |
| Cytochrome P450 monooxygenase | 2R | [GenBank: | 2.9 | 8.59 × 10-05 | 3.0 | 6.76 × 10-07 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 2.9 | 2.08 × 10-06 | - | n.s. | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 2.8 | 1.45 × 10-05 | 3.7 | 2.31 × 10-11 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 2.3 | 2.01 × 10-05 | - | n.s. | |
| Cytochrome P450 monooxygenase | 2R | [GenBank: | 2.2 | 1.68 × 10-09 | 2.7 | 1.66 × 10-07 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 2.1 | 9.58 × 10-09 | 2.1 | 3.55 × 10-04 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | 2.1 | 3.92 × 10-06 | 3.4 | 6.83 × 10-15 | |
| Midgut maltase-like protein | 3L | [GenBank: | 1.6 | 7.58 × 10-07 | 3.0 | 4.33 × 10-07 | |
| Cytochrome P450 monooxygenase | 2R | [GenBank: | 1.5 | 4.59 × 10-06 | 2.3 | 1.93 × 10-07 | |
| Peroxidase | 3L | [GenBank: | - | n.s. | 3.1 | 1.83 × 10-04 | |
| Cytochrome P450 monooxygenase | 3R | [GenBank: | - | n.s. | 2.3 | 1.04 × 10-08 | |
| Genes over-expressed in females | |||||||
| Glutathione S-transferase | X | [GenBank: | 1.9 | 1.99 × 10-08 | 4.8 | 1.38 × 10-11 | |
| Peroxidase | 3L | [GenBank: | 1.8 | 7.25 × 10-04 | 2.1 | 1.47 × 10-05 | |
| Thioredoxin peroxidase | X | [GenBank: | 1.8 | 2.39 × 10-07 | 2.5 | 5.02 × 10-14 | |
| Cu-Zn superoxide dismutase | 2L | [GenBank: | 1.5 | 4.25 × 10-07 | 3.5 | 2.11 × 10-04 | |
| Cytochrome P450 monooxygenase | X | [GenBank: | - | n.s. | 3.1 | 7.08 × 10-14 | |
| Glutathione S-transferase | 2R | [GenBank: | - | n.s. | 2.0 | 3.72 × 10-04 | |
Only genes are listed which showed at least a two-fold difference in one or both strains. p-values were corrected for multiple testing as described in the materials and methods section. n.s., p ≥ 0.001. *CYP6Z1 was spotted on the detox chip as both cDNA and 70-mer oligonucleotide probe [16].
Figure 3Semi-quantitative RT-PCR validation of selected microarray data. Gene expression levels of CYP307A1 and CYP6M2 between females and males of the susceptible Kisumu strain were compared. (A) Peak intensities of amplified cDNA products of the two target mRNAs were measured and normalised by the internal control, the ribosomal S7 product. Primers used to amplify cDNA are shown in Table 1. (B) Measurements were taken from four biological replicates for each sex (15 one-day adult mosquitoes per replicates). Dots represent normalised peak intensities for each replicate. Horizontal bars show mean values. CYP307A1 shows a 3.4-fold over-expression in males (one-sided t-test, p < 0.001) whereas CYP6M2 was 1.1-fold over-expressed in males but statistically not significant (one-sided t-test, p = 0.3).
Sequences of oligonucleotide primers used in semi-quantitative RT-PCR validation experiments
| Gene | Accession number | Primer | Sequence (5' to 3') | Transcript length |
| [GenBank: | CYP6M2_F | GTATGATGCAGGCCCGTATAG | 112 bp | |
| [GenBank: | CYP307A1_F | ACTACGAGCTGAACACGAGTGA | 253 bp | |
| [GenBank: | SPC | GTGCCGGTGCCGAAACAGAA | 472 bp |
Only genes are listed which showed at least a two-fold difference in one or both strains. p-values were corrected for multiple testing as described in the materials and methods section. n.s., p = 0.001. *CYP6Z1 was spotted on the detox chip as both cDNA and 70-mer oligonucleotide probe [16].